Call UsCall Us :

Bortesam Bortezomib Injection IP

Bortesam Bortezomib Injection IP
Bortesam Bortezomib Injection IP
Send Inquiry
Product Code : 01
Product Description

Bortesam Bortezomib Injection IP can suppress the growth of many cancer cells, which can lead to deadly condition. This is useful to treat several conditions known as myeloma as well as mantle cell lymphoma. Offered cancer medications are necessary for the successful treatment of cancer and contribute the speedy recovery of patients. Bortesam Bortezomib Injection IP is a solution administered to the patients via an injection; both intravenous or subcutaneous. Useful for many clinical trials, these optimum-grade medicates of safe utilization are necessary for various therapeutic efficacy. 

Specification

Manufactured By

Samarth

Packaging Type

Box

Brand

Bortesam

Form of Medicine

Injection

Certification

FDA

 


Maheshwari Medical Agency
X